Cannabis & Wellness

As Vireo becomes a top U.S. operator with its Cannabist asset buy, the deal reveals the brutal consolidation and strategic pivots defining the cannabis economy.

A product sold in gas stations is now a Schedule I drug in Kansas. How a legislative sleight of hand created a new class of felons and what it signals.

Standard Wellness is entering its hometown Cleveland market by divesting two historic dispensaries, a move that reveals a maturing, strategic Ohio cannabis industry.

While California's cannabis market struggles, MWG Holdings posts record growth. We explore their community-first model and data-driven tech defying industry trends.

Aurora Cannabis is the first of its kind on TIME's Best Companies list. We dissect the metrics—from finance to culture—to see if this is a PR coup or a new standard.

The wellness brand is leaving multi-level marketing behind for a new referral model. It’s a bold bet on authentic recommendations over recruitment.

Luxury resorts are embracing CBD, blending ancient hot springs with modern botanicals. But does the science support the hype, and what does this say about us?

Speakeasy Dispensary's new Corbin location is more than a store; it's a test case for patient access, economic growth, and destigmatization in Kentucky.

Lifted Made's Highlandia THC beverage is a top seller in Wisconsin, but its success story is more than a local win—it's a case study in navigating a market on the brink of a federal regulatory cliff.

The DEA's move to schedule synthetic 7-OH creates a new regulatory moat. For companies like VIVAZEN, it’s a strategic bet on transparency. For the industry, it’s a forced maturation.

With its new quadruple-filtered THC mixer, cbdMD is betting on clarity and compliance to win a booming but chaotic market. Is this innovation or a savvy survival play?

In a market rife with hype and regulatory gaps, a new initiative is betting that transparent data, not bold claims, will define the future of the CBD industry.

AWH's DEA registration filing signals a new chapter for medical cannabis. This strategic move to navigate Schedule III could unlock massive tax breaks and reshape the industry.

A new survey reveals most kratom users don't understand the product. This isn't just a consumer issue; it’s a test of an industry's ability to build trust.

Tilray's acquisition of telehealth platform HelloMD isn't just about cannabis; it's a strategic play for a vertically integrated, 'seed-to-care' empire.

As the Netherlands is gripped by 'Oranjegekte', one cannabis firm is making a brilliant cultural play. A deep dive into the strategy behind the marketing.

Verano's upcoming Q2 report is a key indicator for the cannabis sector. We look at the strategic moves, from stock splits to rescheduling, setting the stage.

With a new dispensary in a former coffee shop on a key commuter route, C3 Industries is testing if a classic retail playbook can win in a market challenged by high prices.

Over 300 workers at a key Ascend Wellness facility are set to strike, raising questions about labor rights and threatening major disruptions statewide.

As the cannabis industry grapples with billions in unpaid invoices, Reklaim Credit Solutions is betting on deep expertise to build the credit system it desperately needs.